NO2780663T3 - - Google Patents

Info

Publication number
NO2780663T3
NO2780663T3 NO12850243A NO12850243A NO2780663T3 NO 2780663 T3 NO2780663 T3 NO 2780663T3 NO 12850243 A NO12850243 A NO 12850243A NO 12850243 A NO12850243 A NO 12850243A NO 2780663 T3 NO2780663 T3 NO 2780663T3
Authority
NO
Norway
Application number
NO12850243A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2780663T3 publication Critical patent/NO2780663T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/712Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/113Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3515Lipophilic moiety, e.g. cholesterol
NO12850243A 2011-09-06 2012-11-12 NO2780663T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161531156P 2011-09-06 2011-09-06

Publications (1)

Publication Number Publication Date
NO2780663T3 true NO2780663T3 (no) 2018-06-23

Family

ID=46845741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12850243A NO2780663T3 (no) 2011-09-06 2012-11-12

Country Status (9)

Country Link
US (1) US9388411B2 (no)
EP (3) EP4008786A3 (no)
CN (1) CN104011208B (no)
CA (2) CA2847726C (no)
ES (1) ES2651515T3 (no)
HU (1) HUE036269T2 (no)
NO (1) NO2780663T3 (no)
PL (1) PL2753696T3 (no)
WO (1) WO2013034653A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10036018B2 (en) 2014-03-10 2018-07-31 Carlo M. Croce Compositions and methods for treating cachexia
CN106999608A (zh) * 2014-09-21 2017-08-01 耶路撒冷希伯来大学伊森姆研究发展公司 为了治疗脂质相关病症而下调mir‑132
US20170246200A1 (en) * 2014-09-22 2017-08-31 UNIVERSITé LAVAL Microrna-132/212 for the treatment of neurodegenerative disorders
CN106924757B (zh) * 2015-12-31 2020-07-24 中国科学院遗传与发育生物学研究所 miR-449c-5p及其拟似物在制备治疗和预防心脏瓣膜疾病产品中的应用
US11311543B2 (en) 2016-05-27 2022-04-26 Yale University Compositions and methods for inhibiting PTPN22
CN107119050B (zh) * 2017-04-11 2021-01-15 深圳市康宁医院 一种能互补结合miR-132和/或miR-212的RNA及其应用
HUE058867T2 (hu) 2017-12-15 2022-09-28 Medizinische Hochschule Hannover Javított vegyület szívelégtelenség kezelésére
AU2020291792A1 (en) * 2019-06-14 2022-01-27 Cardior Pharmaceuticals Gmbh Treatment of heart failure in human subjects
IT201900024448A1 (it) * 2019-12-18 2021-06-18 Addax Biosciences S R L Conservazione di sequenze di acidi nucleici mediante fissazione dei tessuti in formalina tamponata preparata utilizzando formaldeide deprivata di acidi
CN113583964B (zh) * 2021-04-02 2023-09-08 四川农业大学 利用miR-212及其靶基因调控卵巢颗粒细胞的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ308053B6 (cs) 2000-12-01 2019-11-27 Max Planck Gesellschaft Izolovaná molekula dvouřetězcové RNA, způsob její výroby a její použití
CA2533701A1 (en) * 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US7575863B2 (en) * 2004-05-28 2009-08-18 Applied Biosystems, Llc Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
PL2056882T3 (pl) * 2006-08-01 2013-03-29 Univ Texas Identyfikacja mikro-RNA, który aktywuje ekspresję łańcucha ciężkiego beta-miozyny
WO2008043521A2 (de) * 2006-10-09 2008-04-17 Julius-Maximilians-Universität Würzburg Microrna (mirna) zur diagnose und therapie von herzerkrankungen
EP2096171A1 (en) * 2008-02-27 2009-09-02 Julius-Maximilians-Universität Würzburg MicroRNA (miRNA) and down-stream targets for diagnostic and therapeutic purposes
WO2010105096A2 (en) 2009-03-11 2010-09-16 University Of Massachusetts Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212)

Also Published As

Publication number Publication date
PL2753696T3 (pl) 2018-06-29
HUE036269T2 (hu) 2018-06-28
EP4008786A3 (en) 2022-08-03
CA3065098A1 (en) 2013-03-14
CA3065098C (en) 2023-08-08
CA2847726C (en) 2023-04-04
EP3301178A1 (en) 2018-04-04
WO2013034653A1 (en) 2013-03-14
CA2847726A1 (en) 2013-03-14
CN104011208B (zh) 2020-04-10
CN104011208A (zh) 2014-08-27
EP2753696B1 (en) 2017-11-22
ES2651515T3 (es) 2018-01-26
US20140275220A1 (en) 2014-09-18
EP4008786A2 (en) 2022-06-08
EP3301178B1 (en) 2021-10-13
US9388411B2 (en) 2016-07-12
EP2753696A1 (en) 2014-07-16

Similar Documents

Publication Publication Date Title
AP3853A (no)
BR112013031251A2 (no)
BR112013027245A2 (no)
BR112013024383A2 (no)
BR112013026905A2 (no)
BR112013023185A2 (no)
BR112013022995A2 (no)
BR112013026744A2 (no)
BR112013023927A2 (no)
BR112013027830A2 (no)
BR112013024365A2 (no)
BR112013028733A2 (no)
BR112013027121A2 (no)
BR112013027452A2 (no)
AP2016009466A0 (no)
BR112013031556A2 (no)
BR112013026790A2 (no)
BR112013024588A2 (no)
BR112013032377A2 (no)
BR112013032380A2 (no)
BR112013032368A2 (no)
BR112013026895A2 (no)
BR112013027761A2 (no)
BR112013027836A2 (no)
BR112013023266A2 (no)